Market Overview:
The global low dosage hydrate inhibitors (LDHI) market is expected to grow at a CAGR of 5.5% from 2018 to 2030. The growth of the LDHI market can be attributed to the increasing demand for oil and gas across the globe. In addition, the growing exploration and production activities in offshore areas are also contributing to the growth of this market. The LDHI market is segmented on the basis of type, application, and region. On the basis of type, it is divided into anti-agglomerate (AA) inhibitors, kinetic hydrate inhibitors (KHI), and others. The AA inhibitor segment dominated this market in 2017 owing to its ability to inhibit agglomeration or clumping together of small water droplets into larger ones that can form hydrates.
Product Definition:
LDHI are used to prevent or reduce the formation of scale in water systems. LDHI can be added to a water system as part of its startup treatment, or they can be injected into the system on an as needed basis.
Anti-Agglomerate (AA) Inhibitors:
Anti- agglomerate (AA) inhibitors are a new type of drug, which is used to treat various types of cancer. The AA inhibitor works by blocking the action of an enzyme that causes cancer cell growth. Anti-agglomerate inhibitors can be used with chemotherapy and radiation therapy for the treatment of different types of cancers such as brain, lung, breast and other tumors.
Kinetic Hydrate Inhibitors (KHI):
The global kinetic hydrate inhibitors (KHI) and it's usage in low dosage hydrate inhibitors (LDHI) market size was valued at USD 1.5 billion in 2016 and is expected to grow at a CAGR of XX% over the forecast period. The growing demand for energy efficiency, reduction of greenhouse gas emissions, and cost-effective nature of KHI are some factors that are anticipated to drive the growth during the forecast period 2017-2027.
Application Insights:
Onshore application dominated the global market with a share of over 80% in 2017. The dominant position can be attributed to the extensive usage of low dosage hydrate inhibitors (LDHI) in onshore activities such as oil & gas production. Onshore LDHI is anticipated to witness high demand owing to its use for preventing agglomeration formation and sedimentation, which are known to hinder efficient drilling operations at various depths.
The offshore segment is expected register the fastest CAGR from 2018 to 2030 owingto an increase in LNG production facilities globally coupled with growing demand for LNG as a fuel source by ships and aircrafts. Increasing exploration & production activities for fossil fuels including coal, crude oil & natural gas, and nuclear power across countries such as China, India Japan U.S.
Regional Analysis:
Asia Pacific LDHI market is expected to grow at a lucrative rate over the forecast period. The growth of this region can be attributed to increasing exploration and production activities in countries such as China, India, Malaysia, Indonesia, Thailand and Vietnam. In addition, rising demand for gasoline and diesel fuel from emerging economies such as China and India is anticipated to drive the Asia Pacific LDHI market over the forecast period.
The Middle East & Africa (MEA) offshore oil industry has witnessed significant development owing to growing petroleum exploration activities in countries including Qatar, Saudi Arabia UAE Kuwait Oman Bahrain etc., which are majorly driving contributors of hydrocarbon reserves across this region.
Growth Factors:
- Increasing demand for low dosage hydrate inhibitors in various industries such as oil & gas, water treatment, and others
- Growing awareness about the benefits of using LDHI products among consumers
- Rising investments by key players in research and development of LDHI products
- Technological advancements in the production of LDHI products
- Growing demand for environmentally friendly and energy-efficient solutions
Scope Of The Report
Report Attributes
Report Details
Report Title
Low Dosage Hydrate Inhibitors (LDHI) Market Research Report
By Type
Anti-Agglomerate (AA) Inhibitors, Kinetic Hydrate Inhibitors (KHI), Others
By Application
Onshore, Offshore
By Companies
BASF, Schlumberger, Arkema, Ashland, ERO CHEM LLC, Halliburton, GE(Baker Hughes), Clariant Chemicals, Ecolab, GasHydrate LLC
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
137
Number of Tables & Figures
96
Customization Available
Yes, the report can be customized as per your need.
Global Low Dosage Hydrate Inhibitors (LDHI) Market Report Segments:
The global Low Dosage Hydrate Inhibitors (LDHI) market is segmented on the basis of:
Types
Anti-Agglomerate (AA) Inhibitors, Kinetic Hydrate Inhibitors (KHI), Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Onshore, Offshore
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- BASF
- Schlumberger
- Arkema
- Ashland
- ERO CHEM LLC
- Halliburton
- GE(Baker Hughes)
- Clariant Chemicals
- Ecolab
- GasHydrate LLC
Highlights of The Low Dosage Hydrate Inhibitors (LDHI) Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Anti-Agglomerate (AA) Inhibitors
- Kinetic Hydrate Inhibitors (KHI)
- Others
- By Application:
- Onshore
- Offshore
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Low Dosage Hydrate Inhibitors (LDHI) Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Low dosage inhibitors (LDHI) are a class of medications that work by preventing the body from absorbing hydration. LDHIs can be used to treat a variety of conditions, including dehydration caused by illness or injury, and chronic kidney disease.
Some of the major players in the low dosage hydrate inhibitors (ldhi) market are BASF, Schlumberger, Arkema, Ashland, ERO CHEM LLC, Halliburton, GE(Baker Hughes), Clariant Chemicals, Ecolab, GasHydrate LLC.
The low dosage hydrate inhibitors (ldhi) market is expected to grow at a compound annual growth rate of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Low Dosage Hydrate Inhibitors (LDHI) Market Overview 4.1 Introduction 4.1.1 Market Taxonomy 4.1.2 Market Definition 4.1.3 Macro-Economic Factors Impacting the Market Growth 4.2 Low Dosage Hydrate Inhibitors (LDHI) Market Dynamics 4.2.1 Market Drivers 4.2.2 Market Restraints 4.2.3 Market Opportunity 4.3 Low Dosage Hydrate Inhibitors (LDHI) Market - Supply Chain Analysis 4.3.1 List of Key Suppliers 4.3.2 List of Key Distributors 4.3.3 List of Key Consumers 4.4 Key Forces Shaping the Low Dosage Hydrate Inhibitors (LDHI) Market 4.4.1 Bargaining Power of Suppliers 4.4.2 Bargaining Power of Buyers 4.4.3 Threat of Substitution 4.4.4 Threat of New Entrants 4.4.5 Competitive Rivalry 4.5 Global Low Dosage Hydrate Inhibitors (LDHI) Market Size & Forecast, 2020-2028 4.5.1 Low Dosage Hydrate Inhibitors (LDHI) Market Size and Y-o-Y Growth 4.5.2 Low Dosage Hydrate Inhibitors (LDHI) Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Anti-Agglomerate (AA) Inhibitors
5.2.2 Kinetic Hydrate Inhibitors (KHI)
5.2.3 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Onshore
6.2.2 Offshore
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Low Dosage Hydrate Inhibitors (LDHI) Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Low Dosage Hydrate Inhibitors (LDHI) Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Anti-Agglomerate (AA) Inhibitors
9.6.2 Kinetic Hydrate Inhibitors (KHI)
9.6.3 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Onshore
9.10.2 Offshore
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Anti-Agglomerate (AA) Inhibitors
10.6.2 Kinetic Hydrate Inhibitors (KHI)
10.6.3 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Onshore
10.10.2 Offshore
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Anti-Agglomerate (AA) Inhibitors
11.6.2 Kinetic Hydrate Inhibitors (KHI)
11.6.3 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Onshore
11.10.2 Offshore
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Anti-Agglomerate (AA) Inhibitors
12.6.2 Kinetic Hydrate Inhibitors (KHI)
12.6.3 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Onshore
12.10.2 Offshore
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Anti-Agglomerate (AA) Inhibitors
13.6.2 Kinetic Hydrate Inhibitors (KHI)
13.6.3 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Onshore
13.10.2 Offshore
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Low Dosage Hydrate Inhibitors (LDHI) Market: Competitive Dashboard
14.2 Global Low Dosage Hydrate Inhibitors (LDHI) Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 BASF
14.3.2 Schlumberger
14.3.3 Arkema
14.3.4 Ashland
14.3.5 ERO CHEM LLC
14.3.6 Halliburton
14.3.7 GE(Baker Hughes)
14.3.8 Clariant Chemicals
14.3.9 Ecolab
14.3.10 GasHydrate LLC